The proposed steep tariffs announced by the US on generic medicines could significantly affect India’s largest pharmaceutical ...
The think tank says Indian generics may remain cost-competitive despite higher tariffs, but higher-value formulations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results